Rezultati pretrage - Cynthia Guzzo

  • Prikaz rezultata 1 – 16 od 16
Detaljiziraj rezultate
  1. 1
    Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002

    Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002 od Alexa B. Kimball, Don Robinson, Ying Wu, Cynthia Guzzo, Newman Yeilding, Clark Paramore, Kathy Fraeman, M Bala

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis

    A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis od Gerald G. Krueger, Richard Langley, Craig L. Leonardi, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Lisa T. Dooley, Mark Lebwohl

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies

    Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies od Kristian Reich, Richard Langley, Mark Lebwohl, Philippe Szapary, Cynthia Guzzo, Newman Yeilding, S. Li, M-C. Hsu, C.E.M. Griffiths

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

    Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial od Christian Antoni, Gerald G. Krueger, Kurt de Vlam, C. Birbara, Anna Beutler, Cynthia Guzzo, Bin Zhou, L T Dooley, Arthur Kavanaugh

    Izdano 2005
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis

    Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis od Omoniyi J. Adedokun, Zhenhua Xu, Lakshmi Padgett, Marion Blank, Jewel Johanns, Anne M. Griffiths, Joyce Ford, Honghui Zhou, Cynthia Guzzo, Hugh M. Davis, Jeffrey S. Hyams

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells

    Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the... od Judith R. Abrams, Susan L. Kelley, Elizabeth Hayes, Toyoko Kikuchi, Michael J. Brown, Sewon Kang, Mark Lebwohl, Cynthia Guzzo, Brian V. Jegasothy, Peter S. Linsley, James G. Krueger

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H<sub>4</sub>R‐antagonist (<scp>JNJ</scp>‐39758979) in <scp>J</scp>apanese adults with moderate atopic dermatitis

    Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H<sub>4</sub>R‐antagonist (<scp>JNJ</scp>‐39758979) in <scp>J</scp>apanese adults wit... od Yoko Murata, Michael Song, Hisayuki Kikuchi, Katsuya Hisamichi, Xie L. Xu, Andrew Greenspan, Mai Kato, Chiun‐Fang Chiou, Takeshi Kato, Cynthia Guzzo, Robin L. Thurmond, Mamitaro Ohtsuki, Masutaka Furue

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

    Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial od Arthur Kavanaugh, Gerald G. Krueger, Anna Beutler, Cynthia Guzzo, Bei Zhou, L T Dooley, Philip J. Mease, Dafna D. Gladman, Kurt de Vlam, Piet Geusens, C. Birbara, D Halter, Christian Antoni

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

    Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis od P. Rutgeerts, Brian G. Feagan, Colleen Marano, Lakshmi Padgett, Richard Strauß, Jewel Johanns, Omoniyi J. Adedokun, Cynthia Guzzo, H. Zhang, J.‐F. COLOMBEL, Walter Reinisch, Peter G. Gibson, William J. Sandborn

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

    Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriat... od Désirée van der Heijde, Arthur Kavanaugh, Dafna D. Gladman, Christian Antoni, Gerald G. Krueger, Cynthia Guzzo, Bin Zhou, Lisa T. Dooley, Kurt de Vlam, Piet Geusens, C. Birbara, D Halter, Anna Beutler

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

    Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis od C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof, Vincent Ho, Roseanne Fidelus-Gort, Newman Yeilding, Cynthia Guzzo, Yichuan Xia, B. Zhou, Shu Li, Lisa T. Dooley, Neil Goldstein, Alan Menter

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

    Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis od William J. Sandborn, Brian G. Feagan, Colleen Marano, Hongyan Zhang, Richard Strauß, Jewel Johanns, Omoniyi J. Adedokun, Cynthia Guzzo, Jean‐Frédéric Colombel, Walter Reinisch, Peter R. Gibson, Judith Collins, Gunnar Järnerot, Paul Rutgeerts

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis od William J. Sandborn, Brian G. Feagan, Colleen Marano, Hongyan Zhang, Richard Strauß, Jewel Johanns, Omoniyi J. Adedokun, Cynthia Guzzo, Jean‐Frédéric Colombel, Walter Reinisch, Peter R. Gibson, Judith Collins, Gunnar Järnerot, Toshifumi Hibi∥, Paul Rutgeerts

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease od William J. Sandborn, Christopher Gasink, Long-Long Gao, Marion Blank, Jewel Johanns, Cynthia Guzzo, Bruce E. Sands, Stephen B. Hanauer, Stephan R. Targan, Paul Rutgeerts, Subrata Ghosh, Willem J.S. de Villiers, Remo Panaccione, Gordon R. Greenberg, Stefan Schreiber, Simon Lichtiger, Brian G. Feagan

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

    CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris od Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo, Brian V. Jegasothy, Michael Goldfarb, Bernard S. Goffe, Alan Menter, Nicholas J. Lowe, Gerald G. Krueger, Michael J. Brown, Russell Weiner, Martin Birkhofer, Garvin L. Warner, Karen Berry, Peter S. Linsley, James G. Krueger, Hans D. Ochs, Susan L. Kelley, Sewon Kang

    Izdano 1999
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Cyclosporine as maintenance therapy in patients with severe psoriasis

    Cyclosporine as maintenance therapy in patients with severe psoriasis od Jerome L. Shupack, Elizabeth Abel, Eugene A. Bauer, Marc D. Brown, Lynn A. Drake, Ruth K. Freinkel, Cynthia Guzzo, John Koo, Norman Levine, Nicholas J. Lowe, Charles J. McDonald, David J. Margolis, Matthew J. Stiller, Bruce U. Wintroub, Carol Bainbridge, Sandra Evans, Susan Hilss, William Mietlowski, Christine M. Winslow, Jay E. Birnbaum

    Izdano 1997
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: